Urology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Martel-Frachet V et al. - After treating the cells with IPP51 for 24 h, the title compound induced a predominant and reversible G2+M accumulation at the prometaphase stage of mitosis. However, when used for a longer period, it leads to cell apoptosis. These results suggest that the compound has potential anticancer activities, which could be useful in bladder cancer treatment.

Related Articles

High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression
BMC Cancer, 11/13/09    Relevance Score: 70%

Evidence-based Principles of Bladder Cancer and Diet
Urology, 10/21/09    Relevance Score: 70%

Incidence analyses of bladder cancer in the Nile delta region of Egypt
Cancer Epidemiology, 10/20/09    Relevance Score: 70%

Biomarkers in bladder cancer
BJU International, 10/01/09    Relevance Score: 70%

Diagnosis and Treatment of Bladder Cancer
American Family Physician, 10/01/09    Relevance Score: 70%

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address